AUS
NZ
UK
CA
USA
IND
Healthcare
Ginkgo Bioworks (NYSE:DNA) Expands Synthetic Biology Platform Scale
December 22, 2025 12:00 AM PST| By Anmol KhazanchiGinkgo Bioworks operates a platform-based synthetic biology model focused on engineering custom microorganisms through integrated laboratory automation, data systems, and scalable biological design services.
Stryker Advances Medical Technology with Innovative Solutions
December 19, 2025 08:23 AM PST| By Anmol KhazanchiStryker overview highlighting MedSurg and Orthopaedics operations, global manufacturing, technological innovation, quality standards, sustainability initiatives, and integrated healthcare solutions.
AMN Healthcare Services (NYSE:AMN) Shares Little Changed Today
December 19, 2025 07:24 AM PST| By Anmol KhazanchiDetailed exploration of AMN Healthcare Services operations, including nurse and physician staffing, technology integration, corporate structure, and regional healthcare service coverage.
Aclaris Therapeutics (NASDAQ:ACRS) Nasdaq Top 100 Biotech Model
December 19, 2025 12:00 AM PST| By Anmol KhazanchiAclaris Therapeutics (NASDAQ:ACRS) advances immune-focused clinical research, remaining visible in biotechnology discussions shaped by innovation themes associated with the nasdaq top 100.
Apyx Medical Corporation (NASDAQ:APYX) Supports Modern Surgical Care
December 19, 2025 12:00 AM PST| By Anmol KhazanchiApyx Medical Corporation designs and manufactures energy-based medical devices, offering helium plasma technology used in open and minimally invasive surgical procedures across global healthcare settings.
Oculis Holding AG (NASDAQ:OCS) Sharpens Clinical Vision Research
December 19, 2025 12:00 AM PST| By Anmol KhazanchiOculis Holding AG focuses on clinical-stage development of ophthalmic therapies addressing retinal, inflammatory, and neuroprotective conditions, supported by structured research, trials, and regulatory-aligned operations.
CAMP4 Therapeutics (Nasdaq:CAMP) Enters Research and License Agreement with GSK
December 18, 2025 04:45 PM PST| By Team Kalkine MediaHighlights,CAMP4 has signed a strategic research, collaboration, and license agreement with GSK covering multiple gene targets.,The agreement includes a USD17.5 million upfront cash payment, with additional milestone payments and tiered royalties pos...
Penumbra (NYSE:PEN) Advances Medical Device Solutions Globally
December 18, 2025 09:43 AM PST| By Anmol KhazanchiPenumbra (NYSE:PEN) develops medical devices for vascular and peripheral care, offering thrombectomy and aspiration solutions with operational support for hospitals and healthcare facilities.
HCA Healthcare (NYSE:HCA) Shares Little Changed in NYSE Trade
December 18, 2025 08:53 AM PST| By Anmol KhazanchiDetailed discussion of HCA Healthcare operations, service scope, regulatory environment, workforce structure, and market classification references within the S&P 500 healthcare landscape.
Charles River Labs (NYSE:CRL) Shares Little Changed in NYSE Trade
December 18, 2025 06:32 AM PST| By Anmol KhazanchiDetailed examination of Charles River Laboratories International activities, service segments, geographic presence, and contextual positioning within the life sciences services sector and major market indexes.
Edwards Lifesciences (NYSE:EW) Shares Little Changed in NYSE Session
December 18, 2025 06:14 AM PST| By Anmol KhazanchiDetailed review of Edwards Lifesciences in the healthcare devices sector, outlining product focus, operational structure, geographic reach, and placement within the NYSE Composite framework.
Sagimet Biosciences (Nasdaq:SGMT) Secures Global License for Resmetirom API in Combination Program
December 18, 2025 02:18 AM PST| By Team Kalkine MediaHighlights,Sagimet Biosciences has entered into a global, exclusive license agreement with TAPI covering resmetirom API intellectual property.,The agreement supports technical evaluation, manufacturing, and potential development of a fixed-dose combi...
Day One Biopharmaceuticals (NASDAQ:DAWN) Gains Visibility Nasdaq Today
December 18, 2025 12:00 AM PST| By Anmol KhazanchiDay One Biopharmaceuticals (NASDAQ:DAWN) focuses on targeted oncology therapies for genomically defined cancers, remaining visible in biotechnology discussions shaped by developments tracked across nasdaq today.
Illumina Inc (NASDAQ:ILMN) Nasdaq Futures Shape Discovery Market Now
December 18, 2025 12:00 AM PST| By Anmol KhazanchiIllumina (NASDAQ:ILMN) advances global genomic research through sequencing technologies, remaining central to life sciences discussions that intersect with broader market narratives linked to nasdaq futures.
CVS Health Corporation (NYSE:CVS) Russell 1000 Integrated Care Role
December 18, 2025 12:00 AM PST| By Anmol KhazanchiCVS Health (NYSE:CVS) delivers integrated healthcare services across insurance, pharmacy, and consumer wellness, maintaining visibility among large healthcare providers classified within the Russell 1000 ETF.
Merck & Co Inc (NYSE:MRK) S&P 500 Futures Healthcare Scale Research
December 18, 2025 12:00 AM PST| By Anmol KhazanchiMerck & Co. (NYSE:MRK) operates across human and animal health segments, with corporate updates often viewed within broader market discussions shaped by s&p 500 futures.
Understanding recent coverage of Koninklijke Philips within healthcare technology
December 17, 2025 05:11 PM PST| By Anmol KhazanchiAn objective examination of recent descriptive coverage surrounding Koninklijke Philips, highlighting healthcare technology operations, market context, and institutional ownership themes without subjective or transactional language.
Boston Scientific (NYSE:BSX) Shares Rise After Strong Device Demand
December 17, 2025 07:53 AM PST| By Anmol KhazanchiBoston Scientific (NYSE:BSX) offers medical devices across multiple specialties, integrating advanced technology and software solutions to support healthcare providers globally.
Haemonetics Expands Medical Solutions Across Global Healthcare
December 17, 2025 07:28 AM PST| By Anmol KhazanchiHaemonetics (NYSE:HAE) provides advanced plasma collection systems, donor management software, and global healthcare solutions, integrating technology for efficient clinical operations and patient care.
Integra LifeSciences Holdings (NASDAQ:IART) Nasdaq Index Procedural Tools
December 17, 2025 12:00 AM PST| By Anmol KhazanchiIntegra LifeSciences (NASDAQ:IART) supports neurosurgery and advanced wound care through specialised medical devices, maintaining visibility within the nasdaq index alongside healthcare-focused technology providers.
